AST 05X
Alternative Names: AST-05XLatest Information Update: 15 Sep 2021
At a glance
- Originator Korea Research Institute of Chemical Technology
- Class Antineoplastics
- Mechanism of Action EIF2AK4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 24 Aug 2021 Early research in Solid tumours in South Korea (unspecified route) (Aston Science company pipeline, August 2021)